Detalhe da pesquisa
1.
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
Neuroendocrinology
; 112(3): 298-310, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940581
2.
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).
Ann Surg Oncol
; 28(12): 7506-7517, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34008138
3.
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.
Neuroendocrinology
; 111(7): 609-630, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971521
4.
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.
Lancet Oncol
; 21(9): e431-e443, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888472
5.
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
N Engl J Med
; 376(2): 125-135, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076709
6.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Eur J Nucl Med Mol Imaging
; 47(10): 2372-2382, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123969
7.
An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis.
Neuroendocrinology
; 110(3-4): 198-216, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266019
8.
Neuroendocrine Neoplasms of the Small Bowel and Pancreas.
Neuroendocrinology
; 110(6): 444-476, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31557758
9.
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
Neuroendocrinology
; 110(3-4): 185-197, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995665
10.
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.
Oncologist
; 24(8): e662-e670, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651397
11.
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease.
Neuroendocrinology
; 108(3): 219-231, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654372
12.
Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers.
Neuroendocrinology
; 107(4): 355-365, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30244255
13.
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 18(12): 1652-1664, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074099
14.
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer.
Neuroendocrinology
; 105(1): 54-66, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27442441
15.
Molecular Genomic Blood Biomarkers for Neuroendocrine Tumors: The Long and Winding Road from Berzelius and Bence Jones to a Neuroendocrine Destination.
Neuroendocrinology
; 111(4): 297-303, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380502
16.
Consensus on biomarkers for neuroendocrine tumour disease.
Lancet Oncol
; 16(9): e435-e446, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26370353
17.
Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.
Neuroendocrinology
; 101(3): 211-22, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765100
18.
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.
Neuroendocrinology
; 101(4): 274-88, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924937
19.
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 Trial.
Neuroendocrinology
; 102(1-2): 18-25, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25824001
20.
Neuroendocrine gastro-enteropancreatic tumors - from eminence based to evidence-based medicine - A Scandinavian view.
Scand J Gastroenterol
; 50(6): 727-39, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25855088